Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

18.10.13	Augustea Bunge Maritime To Form JV With York Capital Management - Quick Facts (RTTNews)
08.11.11	Toviaz Top-Line Primary Endpoint Results Positive In Overactive Bladder Study Of Nocturnal Urinary Urgency (Businesswire)
07.11.11	Pfizer To Present Clinical Data From Its Hematology Portfolio At The 53rd Annual Meeting Of The American Society Of Hematology (Businesswire)
26.10.11	Peggy Fleming and the Makers of Robitussin® Provide Relief this Cold and Flu Season with a Simple Question: "Does Your Last Name Sound Contagious?" (Businesswire)
29.09.11	The National Association Of Boards Of Pharmacy And Pfizer Partner To Educate Patients About The Flood Of Counterfeit Medicines Online (Businesswire)
13.09.11	Pfizer to Present Clinical Data from Oncology Portfolio at the 2011 European Multidisciplinary Cancer Congress (Businesswire)
08.09.11	Pfizer Announces Detailed Pivotal Data for Investigational Compound Tofacitinib in Rheumatoid Arthritis to be Presented at American College of Rheumatology 2011 Annual Scientific Meeting (Businesswire)
09.06.11	Pfizer Recognized By CIO Magazine As One Of The CIO 100 Award Honorees (Businesswire)
08.06.11	Boston’s Top Academic Medical Centers Join Pfizer’s Centers For Therapeutic Innovation (Businesswire)
22.05.11	Adding Inspra® (eplerenone) To Standard Therapy Reduces The Incidence Of New Onset Atrial Fibrillation/Flutter (AF/F) In Patients With Systolic Heart Failure, Sub-Analysis Shows (Businesswire)
20.05.11	ELIQUIS® (apixaban) Approved In Europe For Preventing Venous Thromboembolism After Elective Hip Or Knee Replacement (Businesswire)
28.04.11	The Briscoe Law Firm Investigates Acxiom Corp. on Behalf of Shareholders for Possible Breaches of Fiduciary Duties by its Officers and Directors (Businesswire)
05.04.11	SpringSoft, Real Intent Host Seminar on Advances in System-On-Chip Functional Verification Sign-off (Businesswire)
23.03.11	SPIRIVA HandiHaler Prolonged Time To First COPD Exacerbation, New Study In NEJM Shows (Businesswire)
04.03.11	Cowen Group, Inc. Announces 2010 Full-Year and Fourth Quarter Financial Results (Businesswire)
28.02.11	XIAPEX® (Collagenase Clostridium Histolyticum) Authorized in the European Union (EU) For Dupuytren’s Contracture (Businesswire)
23.04.10	World Bank And Pfizer Announce Initiative To Help Improve Healthcare Delivery In Developing Countries (Businesswire)
14.04.10	UnitedHealth Group Launches Innovative Alliance Providing Free Access to Programs That Help Prevent and Control Diabetes and Obesity (Businesswire)
14.04.10	Pfizer Oncology To Present Over 30 Abstracts On Pre-Clinical And Clinical Research At The American Association For Cancer Research Annual Meeting (Businesswire)
23.02.10	Lilly, Merck, And Pfizer Join Forces To Accelerate Research And Improve Treatment Of Lung And Gastric Cancers In Asia (Businesswire)
21.01.10	Pfizer and Auxilium Announce Commencement of European Regulatory Review of XIAFLEXTM for the Treatment of Dupuytren’s Contracture (Businesswire)
05.01.10	King Pharmaceuticals To Present At J.P. Morgan Healthcare Conference (Businesswire)
29.12.09	Pfizer Discontinues A Phase 3 Trial Of Figitumumab In Non-Small Cell Lung Cancer (NSCLC) For Futility (Businesswire)
24.12.09	Pfizer’s Lyrica Receives Complete Response Letter From FDA For Generalized Anxiety Disorder Monotherapy Treatment (Businesswire)
17.12.09	FDA Approves SPIRIVA® HandiHaler® for the Reduction of COPD Exacerbations (Businesswire)
11.12.09	Pfizer Receives European Authorization For Prevenar 13* For The Prevention Of Pneumococcal Disease In Infants And Young Children (Businesswire)
10.12.09	Pfizer Announces Updated Trial Results for AROMASIN® (exemestane tablets) In Switch And Upfront Settings (Businesswire)
20.11.09	FDA Approves Intravenous Formulation Of Pfizer’s Revatio® (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension (Businesswire)
27.10.09	King Pharmaceuticals Licenses Exclusive Rights to CYANOKIT® in U.S. (Businesswire)
20.10.09	Pfizer Reports Third-Quarter 2009 Results (Businesswire)
22.09.09	Survival Benefit Maintained in Long Term Follow-up of IES with Pfizer’s AROMASIN® (Exemestane Tablets) (Businesswire)
30.05.09	Pfizer Data Identify Certain Lung Cancer Patients Who May Benefit from Treatment with Figitumumab (Businesswire)
29.05.09	New Pfizer Data Helps to Identify Kidney Cancer Patients Who May Be Most Likely to Benefit from Treatment (Businesswire)
19.05.09	Addition of Lyrica Significantly Improved Generalized Anxiety Disorder Symptoms in Patients Who Responded Only Partially to Previous GAD Treatments (Businesswire)
07.05.09	King Pharmaceuticals Presents Safety, Efficacy and Measurement Data from Expanded Pain Portfolio (Businesswire)
24.04.09	Pfizer Supports The Global Fight Against Malaria And Commemorates World Malaria Day – "Counting Malaria Out” (Businesswire)
22.04.09	Pfizer and Medicines for Malaria Venture Advancing International Research Efforts in the Fight against Malaria (Businesswire)
22.04.09	New Findings from Global Survey of Women Living with Metastatic Breast Cancer Highlight Strategies to Improve Patient Enrollment in Clinical Trials (Businesswire)
13.03.09	Wide-Reaching Global Survey Reveals Majority of Women Living with Metastatic Breast Cancer Desire Increased Public Attention (Businesswire)
26.02.09	King Pharmaceuticals Reports Year-End and Fourth-Quarter 2008 Financial Results (Businesswire)
27.01.09	Pfizer Invites Public to Listen to Audio-Only Webcast of January 27 Investor Luncheon (Businesswire)
26.01.09	Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company (Businesswire)
18.12.08	King Pharmaceuticals Announces Submission of New Drug Application for CorVue™ (Businesswire)
11.12.08	Pfizer Announces Results from Trial of AROMASIN in Postmenopausal Women with Hormone Sensitive Early Breast Cancer (Businesswire)
06.11.08	Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference (Businesswire)
26.10.08	Pfizer's Novel HIV/AIDS Treatment Selzentry(TM) (Maraviroc) Demonstrates Increased Efficacy Rate In Treatment-Naive HIV Patients (Businesswire)
21.10.08	Pfizer Reports Third-Quarter 2008 Results (Businesswire)
14.10.08	New Data across Pfizer's Pain and Inflammation Portfolio to Be Presented at Upcoming ACR Meeting (Businesswire)
26.09.08	King Pharmaceuticals Responds to Alpharma Inc. (Businesswire)
15.09.08	Pfizer Oncology Presents Safety and Efficacy Results Of CP-751,871 Study At ESMO 2008 (Businesswire)
22.08.08	King Proposes Acquisition of Alpharma for $33 Per Share in Cash (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

18:01		Starker Wochentag in New York: NASDAQ Composite liegt am Donnerstagmittag im Plus
18:01		Zuversicht in New York: S&P 500 mittags mit grünem Vorzeichen
18:01		NASDAQ 100 aktuell: NASDAQ 100 am Mittag mit positivem Vorzeichen
17:58		LSE-Handel FTSE 100 notiert letztendlich im Minus
17:58		Schwacher Handel in Zürich: SMI zum Handelsende in Rot
17:58		Donnerstagshandel in Zürich: SPI sackt zum Ende des Donnerstagshandels ab
17:55		Roche-Aktie gewinnt: Roche vermeldet Forschungsrückschlag - Mittel verfehlt primären Endpunkt
16:01		Freundlicher Handel: Dow Jones zum Handelsstart mit Zuschlägen

18:01

Starker Wochentag in New York: NASDAQ Composite liegt am Donnerstagmittag im Plus

18:01

Zuversicht in New York: S&P 500 mittags mit grünem Vorzeichen

18:01

NASDAQ 100 aktuell: NASDAQ 100 am Mittag mit positivem Vorzeichen

17:58

LSE-Handel FTSE 100 notiert letztendlich im Minus

17:58

Schwacher Handel in Zürich: SMI zum Handelsende in Rot

17:58

Donnerstagshandel in Zürich: SPI sackt zum Ende des Donnerstagshandels ab

17:55

Roche-Aktie gewinnt: Roche vermeldet Forschungsrückschlag - Mittel verfehlt primären Endpunkt

16:01

Freundlicher Handel: Dow Jones zum Handelsstart mit Zuschlägen

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nestle	74.20	0.13 %	K V
Swiss Life Hldg	689.40	0.06 %	K V
Kuehne+Nagel Int	202.30	0.00 %	K V
Swisscom	501.50	-0.30 %	K V
Swiss Re	129.10	-0.39 %	K V
Logitech Intl	73.02	-2.41 %	K V
Roche Hldg G	246.70	-3.25 %	K V
UBS Group	26.89	-3.34 %	K V
Part Grp Hldg	1’217.00	-4.29 %	K V
ABB	48.73	-5.42 %	K V

Nachrichten zu Pfizer Inc.

Aktien Top/Flop

Pfizer Peer Group Nachrichten

Meistgelesene Nachrichten